Ardelyx (ARDX) Cash & Equivalents Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 67.78% |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | 1.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30% |
| Dec 31, 2025 | 4.72% |
| Sep 30, 2025 | -9.94% |
| Jun 30, 2025 | 114.96% |
| Mar 31, 2025 | -14.77% |
| Dec 31, 2024 | 202.43% |
| Sep 30, 2024 | 40.46% |
| Jun 30, 2024 | 39.36% |
| Mar 31, 2024 | -60.92% |
| Dec 31, 2023 | -77.67% |
| Sep 30, 2023 | -45.21% |
| Jun 30, 2023 | -43.72% |
| Mar 31, 2023 | 96.46% |
| Dec 31, 2022 | 32.74% |
| Sep 30, 2022 | -18.14% |
| Jun 30, 2022 | -38.43% |
| Mar 31, 2022 | -44.00% |
| Dec 31, 2021 | -20.44% |
| Sep 30, 2021 | -17.27% |
| Jun 30, 2021 | -13.68% |
| Mar 31, 2021 | -20.61% |
| Dec 31, 2020 | -49.74% |
| Sep 30, 2020 | -1.80% |
| Jun 30, 2020 | 12.13% |
| Mar 31, 2020 | 15.06% |
| Dec 31, 2019 | 129.96% |
| Sep 30, 2019 | 23.54% |
| Jun 30, 2019 | -2.32% |
| Mar 31, 2019 | 35.86% |
| Dec 31, 2018 | 4.49% |
| Sep 30, 2018 | 26.17% |
| Jun 30, 2018 | 44.18% |
| Mar 31, 2018 | -4.87% |
| Dec 31, 2017 | 1.05% |
| Sep 30, 2017 | -62.92% |
| Jun 30, 2017 | -56.61% |
| Mar 31, 2017 | -58.52% |
| Dec 31, 2016 | -30.28% |
| Sep 30, 2016 | 24.26% |
| Jun 30, 2016 | 3.63% |
| Mar 31, 2016 | 74.62% |
| Dec 31, 2015 | -0.26% |
| Sep 30, 2015 | 15.18% |
| Jun 30, 2015 | 20.13% |
| Mar 31, 2015 | 195.95% |
| Dec 31, 2014 | 211.56% |
| Sep 30, 2014 | 376.22% |
| Jun 30, 2014 | 396.08% |